Pressmeddelanden, rapporter och bolagsmeddelande för Inhalation Sciences
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: Inhalation Sciences receives landmark FDA approval for co-financing of its study to validate DissolvIt as a standard research method in the US
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: Inhalation Sciences receives landmark FDA approval for co-financing of its study to validate DissolvIt as a standard research method in the US
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: Inhalation Sciences submits abstract to present landmark data from PreciseInhale clinical study at DDL 2022
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: Inhalation Research Services chosen for new research project worth 1.45 million SEK by US pharma company
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: PreciseInhale delivers high precision and novel results in new study on inhaled household pollutant in Journal of Environmental Science and Pollution Research
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: PreciseInhale delivers high precision and novel results in new study on inhaled household pollutant in Journal of Environmental Science and Pollution Research
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: Inhalation Sciences signs new IRS contract with returning customer
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: Inhalation Sciences announces outcome of exercise of warrants of series TO 1
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: Inhalation Sciences meddelar utfall av utnyttjande av teckningsoptioner av serie TO 1
Spotlight News
Nyhetsuppdatering från Inhalation Sciences
Press release from Companies: Inhalation Sciences meddelar utfall av utnyttjande av teckningsoptioner av serie TO 1